Atlas Trials

Study of the Experience of Patients With Osteoporosis Using the Forteo B Pen to Self Administer Once Daily Teriparatide Therapy

Clinical trial NCT00577863 · COMPLETED

Trial details

NCT number
NCT00577863
Sponsor
Eli Lilly and Company
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Osteoporosis
Start date
2008-01-01
Primary completion
2008-05-01
Enrollment
200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.